ALB · US
Albemarle (ALB) · Lithium & specialties
Albemarle Q2'26 rev $1.74B (+31%), Li $19.53/kg, 65 kt LCE. Battery competition.
Cite a section with a deep link, e.g. /en/r/alb-us-research#thesis
Market snapshot
- Price (~)
- USD 143
- Market cap (~)
- USD 17.0B
- Q2'26 revenue
- USD 1.7B
- Li price Q2 ($/kg)
- USD 19.53
As-of 2026-09-25 (weekly refresh; equities aligned to §A. Missing series are N/A/null. Not investment advice.)
Thesis
Albemarle (NYSE: ALB) is the largest Western lithium producer — integrated from brine/resource to LCE conversion. Q2'26 revenue $1.74B (+31%), net income $480M, adj. EBITDA $858M, lithium realized $19.53/kg, sales 65 kt LCE. Price ~$143; market cap ~$17B.
After the 2023–24 lithium downturn, Q2'26 shows margin recovery — but the market debates sustainability of $19+/kg vs Chinese supply. Battery demand map: China power battery competition 2026. Peers: SQM, LAC.
Business
Model: ALB sells battery-grade lithium (carbonate/hydroxide) and bromine/specialties. Lithium revenue = volume × realized price − conversion cost.
Flagship lines:
- Lithium (~70%+ rev) — Chile brine (Salar de Atacama), US conversion (Kings Mountain, etc.), Australia spodumene JV.
- Bromine / Specialties — higher-margin chemical franchise diversifies cycle.
Competitiveness:
- Integrated resource base — multi-decade brine/spodumene assets vs Chinese refinery-only peers.
- Scale: 65 kt LCE Q2'26 sales at $19.53/kg realized.
Strategy (12–24m): Cost-out program, selective capex on US/EU conversion; match supply to EV demand recovery.
Entity / boundary: Albemarle Corporation (ALB). No material restructuring in 24m.
Strategy pillars
| Pillar | Content |
|---|---|
| Cost-out | Fixed cost reduction through downturn |
| US/EU conversion | Regional supply for IRA/OEM |
| Volume discipline | Match output to demand recovery |
Value chain
Position: Midstream/upstream lithium value chain — resource → conversion → cathode/battery makers.
| Direction | Parties | Notes |
|---|---|---|
| Upstream | Brine/spodumene resources, energy, reagents | Chile water/permitting |
| Downstream | CATL, LG, Panasonic, US/EU cell makers | Price linked to carbonate index |
Customer concentration: Top battery OEMs and traders — Top5 customers material but typically no single >30% disclosed; diversified geographies.
Supply-chain risks: (1) Chinese lithium oversupply compressing price; (2) Chile royalty/water regulation on Salar de Atacama.
Customers & contract mix
| Item | Value | Note |
|---|---|---|
| Battery OEMs | Global top-tier cell makers | Top5 material |
| Traders/converters | Index-linked contracts | |
| Geography | Asia + US/EU | China demand key |
Corporate events
2024–2026: Cost reduction program, capex deferrals through downturn; Q2'26 earnings inflection on volume + price recovery.
Corporate events
| Date | Phase | Event | Meaning |
|---|---|---|---|
| 2024 | Operations | Capex deferrals/cost-out | Downturn response |
| 2025-H2 | Market | Lithium price stabilization | Margin trough passed |
| 2026-Q2 | Earnings | Rev $1.74B; EBITDA $858M | Recovery quarter |
Valuation
Price ~$143 (Aug 2026); market cap ~$17B. ~20–25x TTM P/E (approx.) off trough earnings recovery. ~1.8x P/B. Dividend yield modest (~1%).
Market prices lithium recovery vs oversupply risk.
Valuation snapshot
| Metric | Value | Note |
|---|---|---|
| Price (~) | ~$143 | Aug 2026 |
| Market cap | ~$17B | |
| P/E (TTM ~) | ~20–25x | Off trough |
| P/B (~) | ~1.8x | |
| Lithium realized Q2 | $19.53/kg | 65 kt LCE sold |
Valuation & returns · ~3y
Interactive chart available in the reader.
Share price · ~3y
Interactive chart available in the reader.
Financial trend (~24 months)
Eight-quarter revenue with Q2'26 $1.74B disclosed. Adj. EBITDA margin ~49% in Q2 ($858M / $1.74B).
Total revenue · last 8 quarters
Interactive chart available in the reader.
Net / EBITDA margin · last 8 quarters
Interactive chart available in the reader.
Financial health (§A.7)
Financial health
| Item | Value | Note |
|---|---|---|
| OCF (H1'26 ~) | Improving | EBITDA recovery |
| Net debt | Elevated | Expansion capex phase |
| Liquidity | Adequate | Revolver access |
| Auditor | Unqualified | No going-concern |
A.7 read: OCF improving with EBITDA recovery; debt elevated from expansion capex but manageable with cost cuts. Liquidity adequate; no going-concern. Auditor unqualified.
Net income · last 8Q
Interactive chart available in the reader.
Operations
Q2'26 drivers:
- Volume: 65 kt LCE sold (+YoY recovery).
- Price: Realized $19.53/kg vs trough ~$10–13/kg in 2024.
- Cost: Cost-out program supports EBITDA rebound.
Operating snapshot
| Item | Value | YoY | Note |
|---|---|---|---|
| Q2'26 revenue | $1.74B | +31% | |
| Q2'26 net income | $480M | Recovery | |
| Adj. EBITDA | $858M | +strong | ~49% margin |
| LCE volume | 65 kt | +YoY | Quarterly sales |
| Li realized price | $19.53/kg | vs trough 2024 |
Competition
Lithium producers compete on cost, resource quality, and ESG/regional qualification (US IRA, EU rules).
Peer comparison
| Company | Position | Margin lens | Strength | Weakness |
|---|---|---|---|---|
| Albemarle ALB (self) | Integrated lithium | Adj EBITDA ~49% Q2 | Brine + conversion; 65 kt LCE Q2 | Chinese oversupply risk |
| SQM | Chile brine | Lower cost | Low-cost Atacama | Governance/overhang |
| Lithium Americas LAC | Developer | Pre-profit | Thacker Pass US asset | Execution/capex risk |
ALB vs SQM: Both Chile brine; SQM lower cost but governance/overhang. LAC pre-revenue/expansion risk — higher beta, no dividend support.
Management
CEO Kent Masters and CFO Neal Sheorey — led cost-out and Q2 recovery. No C-suite turnover in 24m — stability high through downturn.
Key management (24m)
| Role | Name | Since | 24m change |
|---|---|---|---|
| CEO | Kent Masters | 2020 | No change |
| CFO | Neal Sheorey | 2023 | No change |
| Chair | Alejandro D. Wolff | 2021 | No change |
Outlook
H2'26: Watch realized price vs spot; volume guidance; US conversion project timelines. Link to battery competition for demand.
Scenarios
| Scenario | Conditions | Implication |
|---|---|---|
| Bull | Lithium >$22/kg; EV demand accelerates | EBITDA >$3.5B run-rate; $180–220 |
| Base | $17–20/kg range; 65–70 kt/qtr | $120–160 |
| Bear | China oversupply; <$14/kg | Losses return; $70–95 |
Risks
{block:table_risks}
{block:risk_note}
Tracking list
- Lithium realized price — Q2 $19.53/kg vs spot carbonate/hydroxide (falsify: <$15/kg two quarters).
- LCE sales volume — Q2 65 kt; FY26 run-rate vs nameplate.
- Adj. EBITDA $858M Q2 — margin recovery sustainability (confirm: EBITDA >$800M next quarter).
- China battery demand — see battery competition map for downstream pull.
- Balance-sheet / capex — Chile/US conversion projects without equity raise (falsify: dilutive raise).
References
- Albemarle Q2 2026 earnings — https://investors.albemarle.com/
- Albemarle lithium market update — https://investors.albemarle.com/
- SEC EDGAR ALB — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000910593
- Battery demand: China power battery competition 2026
- NYSE ALB — https://www.nyse.com/quote/XNYS:ALB
Figures marked (~) are approximate where quarterly detail was not fully disclosed. Not investment advice.
Comments
Sign in to comment